+1 888-880-9539Search News by Tag: food and drug administration
448 news stories found
Press Release
February 10, 2010
A Class I Recall is the most type of recall issued by the FDA. It means that there is a reasonable probability that the product will cause a serious adverse health event or death if used.
Read Press Release
Press Release
February 1, 2010
Grant Medical Center and the OhioHealth Medical Specialty Foundation opened a practice dedicated to arthritis and other diseases of the joints, muscles and bones.
Read Press Release
Press Release
January 31, 2010
The primary difference between BOTOX and Juvederm is that BOTOX is a muscle relaxer and Juvederm is a tissue filler. Because it is a muscle relaxer, the injectable solution inside a BOTOX injection is a refined solution of botulinum toxin type A.
Read Press Release
Press Release
January 31, 2010
Latisse is a prescription drug used to grow eyelashes that are thicker, fuller and longer. This product is the only one approved by the Food and Drug Administration (FDA) to treat hypotrichosis, a condition characterized by a lack of hair growth.
Read Press Release
Press Release
January 9, 2010
Largely, dental myths imply that dentist enjoy causing pain, or provide unnecessary work to bilk innocent customers out of their hard earned cash. Others still are just based on ignorance of the way our teeth work.
Read Press Release
Press Release
December 18, 2009
An independent laboratory has found that BIOGUARD barrier gauze dressings with Quick-Med's novel NIMBUS antimicrobial technology exhibit high antiviral efficacy against the H1N1 virus.
Read Press Release
Press Release
December 12, 2009
Latisse is the only Food and Drug Administration (FDA) approved treatment for hypotrichosis to grow eyelashes.
Read Press Release
Press Release
December 9, 2009
SigmaPhone.com has released the FDA Drugs app, its flagship and one of the top paid medical apps in iPhone App Store, for Android. Both iPhone/iTouch and Android users can download the app from iTune Store or Android market.
Read Press Release
Press Release
December 8, 2009
Eidogen-Sertanty licensed their Target Informatics Platform (TIP) to the U.S. Food and Drug Administration's National Center for Toxicological Research (NCTR).
Read Press Release
Press Release
December 6, 2009
Patients may contact the Bard Compsix Kugel Mesh Hernia Patch Patient Information Web site and call 1-866-374-0338 to see if they qualify to file a claim for Kugel Mesh Hernia Patch settlement compensation and medical monitoring.
Read Press Release
Press Release
November 20, 2009
Dysport has been called a virtual twin of BOTOX. It is made from the same type of botulinum toxin as BOTOX and it works the same way BOTOX does by paralyzing the muscles.
Read Press Release
Press Release
November 8, 2009
The most popular cosmetic treatment in the United Sates is BOTOX injections to treat wrinkles. In 2007, the latest year for statistics, the American Society of Plastic Surgeons reports that more than 4.5 million BOTOX treatments were given.
Read Press Release
Press Release
October 24, 2009
On May 29, 2009, the Food and Drug Administration and Penumbra Inc. notified healthcare workers that a Class I recall was beginning for the Penumbra Neuron 5F Select Catheter.
Read Press Release
Press Release
October 14, 2009
BOTOX has been in use for over a decade to treat people suffering from conditions related to overactive muscles. Recently, the most common use has become very successfully treating those with facial lines and wrinkles.
Read Press Release
Press Release
September 4, 2009
Dr. David Digiallorenzo purchased a PerioLase from Millennium Dental Technologies in May 2009 and since then, patient satisfaction among those who have undergone laser therapy has been 100 percent.
Read Press Release
Press Release
September 3, 2009
Drug companies increasingly find it difficult to recruit enough eligible lupus patients to participate in their clinical trials. The LFA will conduct a live web chat to provide patients the information they need to make an informed decision.
Read Press Release
Press Release
July 23, 2009
Brightmark Books announces the release of Dr. Donald Robbins' new book, The Toxic Dental Office: How to Protect Yourself and Your Family. Robbins paints a "disturbing picture of patient risk" and the ADA's role in promoting mercury and fluoride.
Read Press Release
Press Release
June 1, 2009
Dr Ira L Shapira And Dr Mark J Amidei Have Recently Incorporated Velscope Oral Diagnosis Screening System Into Their Dental Practice. They Have Always Made Early Cancer Detection A Significant Part Of Their Practice For The Last 25 Years.
Read Press Release
Press Release
May 30, 2009
In addition to liver damage, the FDA determined that a number of serious illnesses have been associated with Hydroxycut use, including cardiovascular injury, seizures, and severe muscle damage known as rhabdomyolysis.
Read Press Release